| Tue, Nov 24, 2009 | | • | The Technical Indicator: U.S. markets hesitate at the 2009 peak
at MarketWatch (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | Become a Recessionista? Not in This Stock Market
TradingMarkets.com (Mon, Nov 23)
| | Sat, Nov 21, 2009 | | • | [$$] The Hunt for Tech Stocks, Broadly Defined
at Barrons.com (Sat, Nov 21)
| | Fri, Nov 20, 2009 | | • | Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
Business Wire (Fri, Nov 20)
| | Tue, Nov 17, 2009 | | • | UPDATE - InterMune to modify hep C study to drop one dosage
at Reuters (Tue, Nov 17)
| | • | InterMune shares fall on change in hepatitis study
AP (Tue, Nov 17)
| | • | Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz
at TheStreet.com (Tue, Nov 17)
| | • | Tech stocks off the beaten path
at Fortune (Tue, Nov 17)
| | • | InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
at TheStreet.com (Tue, Nov 17)
| | • | Vertex Pharm downgraded by Merriman
Briefing.com (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | • | VERTEX PHARMACEUTICALS INC / MA Financials
EDGAR Online Financials (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | • | The Great Reaction
at Forbes.com (Thu, Nov 12)
| | • | Dr Elias Zerhouni Picks the 7 Most Powerful People in Medicine
at Forbes.com (Thu, Nov 12)
| | • | Vertex Pharmaceuticals Announces Webcast of its Presentation at the Lazard Capital Markets Annual Healthcare Conference
Business Wire (Thu, Nov 12)
| | • | Do You Have the Guts to Buy?
at Motley Fool (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | Healthcare Guru Adds Selected Biotech, Pharma Stakes
Indie Research (Wed, Nov 11)
| | • | Vertex Pharma trades 2013 debt for new shares
AP (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | Vertex Pharmaceuticals Announces Agreements to Exchange $109.0 Million of its 2013 Convertible Senior Subordinated Notes into Common Stock
Business Wire (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | • | VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
|
Add VRTX News to My Yahoo!:
 
| |
|
1.48% Nasdaq 0.00%
Headlines
